Crabbe, J. C., Wahlsten, D., and Dudek, B. C.(1999).Genetics of mouse behavior: interactions with laboratory environ- ment. Science 284, 1670–1672. Crawley, J. N. (2004). Designing mouse behavioral tasks relevant to autistic- like behaviors. Ment. Retard Dev. Disabil. Res. Rev. 10, 248–258. D’Adamo, P., Wolfer, D. P., Kopp, C., Tobler, I., Toniolo, D., and Lipp, H. P. (2004). Mice deﬁcient for the synaptic vesicle protein Rab3a show impaired spatial reversal learning and increased explorative activity but none of the behavioral changes shown by mice deﬁcient for the Rab3a regulator Gdi1. Eur. J. Neurosci. 19, 1895–1905. Dawson, D. A., Grant, B. F., and Ruan, W. J. (2005). The association between stress and drinking: modifying effects of gender and vulnerability. Alcohol Alcohol. 40, 453–460. De Steno, D. A., and Schmauss, C. (2009). A role for dopamine D2 receptors in reversal learning. Neuroscience 162, 118–127. Egerton, A., Reid, L., McGregor, S., Cochran, S. M., Morris, B. J., and Pratt, J. A. (2008). Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats. Psychopharmacology (Berl.) 198, 37–49. Egerton, A., Reid, L., McKerchar, C. E., Morris, B. J., and Pratt, J. A. (2005). Impairment in perceptual atten- tional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophre- nia. Psychopharmacology (Berl.) 179, 77–84. Ehrman, L. A., Williams, M. T., Schaefer, T. L., Gudelsky, G. A., Reed, T. M., Fienberg, A. A., Greengard, P., and Vorhees, C. V. (2006). Phosphodiesterase 1B differentially modulates the effects of metham- phetamine on locomotor activity and spatial learning through DARPP32- dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice. Genes Brain Behav. 5, 540–551. Elias, M. F., and Eleftheriou, B. E. (1972). Reversal learning and RNA labeling in neurological mutant mice and normal littermates. Physiol. Behav. 9, 27–34. Elliott, R., McKenna, P. J., Robbins, T. W., and Sahakian, B. J. (1995). Neuropsychological evidence for frontostriatal dysfunction in schizo- phrenia. Psychol. Med. 25, 619–630. Feldon, J., and Weiner, I. (1992). From an animal model of an attentional deﬁcit towards new insights into the pathophysiology of schizophrenia. J. Psychiatr. Res. 26, 345–366. Ferry, A. T., Lu, X. C., and Price, J. L. (2000). Effects of excitotoxic lesions Frontiers in Neuroscience in the ventral striatopallidal–thalam- ocortical pathway on odor reversal learning: inability to extinguish an incorrect response. Exp. Brain Res. 131, 320–335. Filali, M., and Lalonde, R. (2009). Age- related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer’s disease. Brain Res. 1292, 93–99. File, S. E., and Seth, P. (2003). A review of 25 years of the social interaction test. Eur. J. Pharmacol. 463, 35–53. Fiorelli, R., Rudolph, U., Straub, C. J., Feldon, J., and Yee, B. K. (2008). Affective and cognitive effects of global deletion of alpha3-containing gamma- aminobutyric acid-A receptors. Behav Pharmacol 19, 582–596. Floresco, S. B., Block, A. E., and Tse, M. T. (2008). Inactivation of the medial prefrontal cortex of the rat impairs strategy set-shifting, but not reversal learning, using a novel, automated procedure. Behav. Brain Res. 190, 85–96. Floresco, S. B., Zhang, Y., and Enomoto, T. (2009). Neural circuits subserving behavioral ﬂexibility and their rele- vance to schizophrenia. Behav. Brain Res. 204, 396–409. Garner, J. P., Thogerson, C. M., Wurbel, H., Murray, J. D., and Mench, J. A. (2006). Animal neuropsychology: validation of the Intra-Dimensional Extra-Dimensional set shifting task for mice. Behav. Brain Res. 173, 53–61. Gass, P., Wolfer, D. P., Balschun, D., Rudolph, D., Frey, U., Lipp, H. P., and Schutz, G. (1998). Deﬁcits in memory tasks of mice with CREB mutations depend on gene dosage. Learn. Mem. 5, 274–288. Gerlai, R., Roder, J. C., and Hampson, D. R. (1998). Altered spatial learn- ing and memory in mice lacking the mGluR4 subtype of metabotropic glutamate receptor. Behav. Neurosci. 112, 525–532. Geyer, M. A., Krebs-Thomson, K., Braff, D. L., and Swerdlow, N. R. (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl.) 156, 117–154. Glickstein, S. B., Desteno, D. A., Hof, P. R., and Schmauss, C. (2005). Mice lack- ing dopamine D2 and D3 receptors exhibit differential activation of pre- frontal cortical neurons during tasks requiring attention. Cereb. Cortex 15, 1016–1024. Goldman-Rakic, P. S. (1996). The prefron- tal landscape: implications of func- tional architecture for understanding human mentation and the central executive. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 351, 1445–1453. Granholm,A. C., Sanders, L.A., and Crnic, L. S. (2000). Loss of cholinergic pheno- type in basal forebrain coincides with cognitive decline in a mouse model of Down’s syndrome. Exp. Neurol. 161, 647–663. Grant, D. A., and Berg, E. A. (1948). A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card- sorting problem. J. Exp. Psychol. 38, 404–411. Hariri, A. R., and Holmes, A. (2006). Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn. Sci. 10, 182–191. Harrison, P. J., and Weinberger, D. R. (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10, 40–68. Hefner, K., Whittle, N., Juhasz, J., Norcross, M., Karlsson, R. M., Saksida, L. M., Bussey, T. J., Singewald, N., and Holmes, A. (2008). Impaired fear extinction learning and cortico-amy- gdala circuit abnormalities in a com- mon genetic mouse strain. J. Neurosci. 28, 8074–8085. Heyser, C. J., Fienberg, A. A., Greengard, P., and Gold, L. H. (2000). DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task. Brain Res. 867, 122–130. Holmes, A., and Wellman, C. L. (2009). Stress-induced prefrontal reorgani- zation and executive dysfunction in rodents. Neurosci. Biobehav. Rev. 33, 773–783. Huang, X. G., Yee, B. K., Nag, S., Chan, S. T., and Tang, F. (2003). Behavioral and neurochemical characterization of transgenic mice carrying the human presenilin-1 gene with or without the leucine-to-proline mutation at codon 235. Exp. Neurol. 183, 673–681. Hutton, S. B., Puri, B. K., Duncan, L. J., Robbins, T.W., Barnes, T. R., and Joyce, E. M. (1998). Executive function in ﬁrst-episode schizophrenia. Psychol. Med. 28, 463–473. Idris, N. F., Repeto, P., Neill, J. C., and Large, C. H. (2005). Investigation of the effects of lamotrigine and cloza- pine in improving reversal-learning impairments induced by acute phen- cyclidine and D-amphetamine in the rat. Psychopharmacology (Berl.) 179, 336–348. InternationalHumanGenomeSequencing Consortium. (2004). Finishing the euchromatic sequence of the human genome. Nature 431, 931–945. Izquierdo, A., Wiedholz, L. M., Millstein, R.A.,Yang, R. J., Bussey, T. J., Saksida, L. M.,and Holmes,A.(2006).Genetic and dopaminergic modulation of reversal learning in a touchscreen-based Cognitive ﬂexibility in mice operant procedure for mice. Behav. Brain Res. 171, 181–188. Javitt, D. C., and Zukin, S. R. (1991). Recent advances in the phencyclid- ine model of schizophrenia. Am. J. Psychiatry 148, 1301–1308. Jentsch, J. D., Redmond, D. E. Jr., Elsworth, J. D., Taylor, J. R., Youngren, K. D., and Roth, R. H. (1997a). Enduring cogni- tive deficits and cortical dopamine dysfunction in monkeys after long- term administration of phencyclidine. Science 277, 953–955. Jentsch, J. D., Tran, A., Le, D., Youngren, K. D., and Roth, R. H. (1997b). Subchronic phencyclidine admin- istration reduces mesoprefrontal dopamine utilization and impairs pre- frontal cortical-dependent cognition in the rat. Neuropsychopharmacology 17, 92–99. Jentsch, J. D., and Roth, R. H. (1999). The neuropsychopharmacology of phencyclidine: from NMDA receptor hy pofunction to the dopamine hypothesis of schizophre- nia. Neuropsychopharmacology 20, 201–225. Jentsch, J. D., Roth, R. H., and Taylor, J. R. (2000). Object retrieval/detour deﬁcits in monkeys produced by prior subchronic phencyclidine administra- tion: evidence for cognitive impulsiv- ity. Biol. Psychiatry 48, 415–424. Jentsch, J. D., and Taylor, J. R. (2001). Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats. Neuropsychopharmacology 24, 66–74. Joyce, E., Hutton, S., Mutsatsa, S., Gibbins, H., Webb, E., Paul, S., Robbins, T., and Barnes, T. (2002). Executive dysfunc- tion in ﬁrst-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. Br. J. Psychiatry Suppl. 43, s38–s44. Karlsson, R. M., Tanaka, K., Heilig, M., and Holmes, A. (2008). Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychoto- mimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist. Biol. Psychiatry 64, 810–814. Karlsson, R. M., Tanaka, K., Saksida, L. M., Bussey, T. J., Heilig, M., and Holmes, A. (2009). Assessment of gluta- mate transporter GLAST (EAAT1)- deficient mice for phenotypes relevant to the negative and executive/ cognitive symptoms of schizophre- nia. Neuropsychopharmacology 34, 1578–1589. Kofman, O., Shavit, Y., Ashkenazi, S., and Gabay, S. (2007). Habituation, discrimination and anxiety in transgenic mice overexpressing May 2010 | Volume 4 | Issue 1 | 27